Case Study: How a Custom Partnership Helped One Diagnostics Company Grow Globally During the COVID-19 Pandemic

This paper summarizes LumiraDx’s move to meet global demands for SARS-CoV-2 testing in response to the COVID-19 pandemic, assisted by our Custom Manufacturing team.

A point-of-care diagnostic company wants to expand their SARS-CoV-2 testing capabilities but needs to efficiently produce reliable enzymes and quickly reach global markets.

Combining LumiraDx’s diagnostic platform with an established pipeline for custom enzyme production resulted in a high-throughput, accurate COVID-19 testing solution for worldwide laboratories to use during a time of extreme uncertainty.